# Hellenic Institute for the Study of Sepsis: Phase 3 study withdrawn (Type 1 Diabetes Mellitus)

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | Hellenic Institute for the Study of Sepsis |
| Sponsor type | Academic and hospital |
| Study | Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment |
| NCT ID | NCT04177303 |
| Phase | Phase 3 |
| Status | withdrawn |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention types | drug |
| Posted | 2019-11-26 |
| Planned start | 2019-11-29 |
| Event | Withdrawn before enrolling |
| Event date | 2026-11-03 |
| Last update posted | 2026-11-03 |

## Why this score
- Posted in the last two weeks.
- Stopped early: budget and sites freed up.
- Phase 3: multi-site, larger budget.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT04177303). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.